The ADME Toxicology Testing Market Size is valued at USD 3.82 Bn in 2023 and is predicted to reach USD 7.12 Bn by the year 2031 at an 8.3% CAGR during the forecast period for 2024-2031.
ADME, which stands for Absorption, Distribution, Metabolism, and Excretion, refers to the studies designed to investigate how a chemical, such as a drug compound, is processed by a living organism. These studies help determine how the drug is absorbed into the bloodstream, distributed throughout the body, metabolized into different substances, and excreted. Toxicology tests, which are often part of this process, provide insights into the potential adverse effects of the drug. When combined, these studies yield the acronym ADMET, which encompasses both the pharmacokinetic and toxicological evaluation necessary for assessing the safety and efficacy of new drug candidates.
ADME toxicology testing helps to identify drugs or chemicals that are likely to be toxic, have poor bioavailability (i.e., they are not well absorbed by the body), or interact with other drugs. Additionally, ADME testing aids in optimizing the dosing of drugs. By addressing these critical aspects, ADME toxicology testing ensures that new drugs are safe and effective for patients. It includes studying acute, chronic, and sub-chronic toxicity, genotoxicity, carcinogenicity, reproductive and developmental toxicity, and other specific toxicological endpoints.
The application of ADME toxicology testing in drug development and chemical safety assessment is multifaceted and crucial. It is used to determine drugs or chemicals likely to be toxic, preventing potential harm to patients and identify potential interactions with other drugs, minimizing adverse effects.
The is segmented based on the type of services, type of assays, type of molecule, end user, and therapeutic areas. By Type of Services segmented into absorption, distribution, metabolism, and excretion. Based on the Type of Assays segmented into batch / fed-batch, continuous. Therapeutic Areas, the market is categorized into blood disorder, cardiovascular disorder, gastrointestinal and vascular disorder, hormonal disorder, infectious diseases, immunological disorders, mental disorders, metabolic disorders, neurological disorders, oncology disorders, respiratory disorders. Type of Molecule segmented into biologics, small molecules. End User segmented into pharmaceutical and biotechnology companies, academic / research institutes.
Based on Therapeutic Areas, the market is categorized into blood disorder, cardiovascular disorder, gastrointestinal and vascular disorder, hormonal disorder, infectious diseases, immunological disorders, mental disorders, metabolic disorders, neurological disorders, oncology disorders, respiratory disorders. Among these, the oncology disorders segment is expected to have the highest growth rate during the forecast period. This is because cancer drug development is a highly active and rapidly evolving area of research and development. Oncology drugs often require extensive ADME testing to ensure they are effectively absorbed, distributed, metabolized, and excreted, as well as to understand their potential toxicological effects. The high prevalence and significant clinical need for effective cancer treatments drive substantial investment and focus in this segment, leading it to dominate the ADME toxicology testing market.
Based on type of Assay, the segment divided into batch / fed-batch, continuous form. Among these, the batch / fed-batch segment dominates the market during the forecast period. Batch and fed-batch processes are more commonly used in the production and testing of pharmaceuticals, including ADME toxicology studies, because they offer greater control over experimental conditions and are well-suited to the scale of most laboratory and preclinical studies. These methods allow for precise adjustments to be made to the testing environment and are easier to manage compared to continuous processes, which are more complex and typically used for large-scale manufacturing rather than initial testing and development phases.
North America, particularly the United States, has a highly developed healthcare infrastructure that supports extensive research and development activities. The region is home to many of the world's leading pharmaceutical companies, which conduct extensive drug development and testing. North America is at the forefront of adopting advanced technologies and methodologies in ADME toxicology testing, improving efficiency and outcomes. The availability of a highly skilled workforce in biomedical and pharmaceutical sciences enhances the capacity for high-quality ADME testing.
| Report Attribute | Specifications |
| Market Size Value In 2023 | USD 3.82 Bn |
| Revenue Forecast In 2031 | USD 7.12 Bn |
| Growth Rate CAGR | CAGR of 8.3% from 2024 to 2031 |
| Quantitative Units | Representation of revenue in US$ Bn and CAGR from 2024 to 2031 |
| Historic Year | 2019 to 2023 |
| Forecast Year | 2024-2031 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | By Type of Services, Type of Assays, Type of Molecule, End User, Therapeutic Areas |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; South East Asia |
| Competitive Landscape | Thermo Fisher Scientific Inc., Promega Corporation, Agilent Technologies, Inc., Charles River Laboratories, RTI International., Eurofins Scientific, Evotec, Galapagos, Tecan Group, GVK Biosciences, Pharmaron, Pharmaceutical Product Development (PPD), Sai Life Sciences, Shanghai Medicilon, Syngene International |
| Customization Scope | Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing and Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global ADME Toxicology Testing Market Snapshot
Chapter 4. Global ADME Toxicology Testing Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: Type of Services Estimates & Trend Analysis
5.1. Type of Services & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following Type of Services:
5.2.1. Absorption
5.2.2. Distribution
5.2.3. Metabolism
5.2.4. Excretion
Chapter 6. Market Segmentation 2: Type of Assays Estimates & Trend Analysis
6.1. Type of Assays & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following Type of Assays:
6.2.1. Batch / Fed-Batch
6.2.2. Continuous
Chapter 7. Market Segmentation 3: Type of Molecules Estimates & Trend Analysis
7.1. Type of Molecules & Market Share, 2019 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following Type of Molecules:
7.2.1. Biologics
7.2.2. Small Molecules
Chapter 8. Market Segmentation 4: End Users Estimates & Trend Analysis
8.1. End Users & Market Share, 2019 & 2031
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following End Users:
8.2.1. Pharmaceutical and Biotechnology Companies
8.2.2. Academic / Research Institutes
Chapter 9. Market Segmentation 5: Therapeutic Areas Estimates & Trend Analysis
9.1. Therapeutic Areas & Market Share, 2019 & 2031
Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following Therapeutic Areas:
9.1.1. Blood Disorder
9.1.2. Cardiovascular Disorder
9.1.3. Gastrointestinal and Vascular Disorder
9.1.4. Hormonal Disorder
9.1.5. Infectious Diseases
9.1.6. Immunological Disorders
9.1.7. Mental Disorders
9.1.8. Metabolic Disorders
9.1.9. Neurological Disorders
9.1.10. Oncology Disorders
9.1.11. Respiratory Disorders
Chapter 10. ADME Toxicology Testing Market Segmentation 4: Regional Estimates & Trend Analysis
10.1. North America
10.1.1. North America ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts Type of Services, 2024-2031
10.1.2. North America ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts Type of Assays, 2024-2031
10.1.3. North America ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts Type of Molecules, 2024-2031
10.1.4. North America ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts End Users, 2024-2031
10.1.5. North America ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts Therapeutic Areas, 2024-2031
10.1.6. North America ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
10.2. Europe
10.2.1. Europe ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts Type of Services, 2024-2031
10.2.2. Europe ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts Type of Assays, 2024-2031
10.2.3. Europe ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts Type of Molecules, 2024-2031
10.2.4. Europe ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts End Users, 2024-2031
10.2.5. Europe ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts Therapeutic Areas, 2024-2031
10.2.6. Europe ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts xx6, 2024-2031
10.2.7. Europe ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
10.3. Asia Pacific
10.3.1. Asia Pacific ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts Type of Services, 2024-2031
10.3.2. Asia Pacific ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts Type of Assays, 2024-2031
10.3.3. Asia-Pacific ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts Type of Molecules, 2024-2031
10.3.4. Asia-Pacific ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts End Users, 2024-2031
10.3.5. Asia-Pacific ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts Therapeutic Areas, 2024-2031
10.3.6. Asia Pacific ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
10.4. Latin America
10.4.1. Latin America ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts Type of Services, 2024-2031
10.4.2. Latin America ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts Type of Assays, 2024-2031
10.4.3. Latin America ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts Type of Molecules, 2024-2031
10.4.4. Latin America ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts End Users, 2024-2031
10.4.5. Latin America ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts Therapeutic Areas, 2024-2031
10.4.6. Latin America ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
10.5. Middle East & Africa
10.5.1. Middle East & Africa ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts Type of Services, 2024-2031
10.5.2. Middle East & Africa ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts Type of Assays, 2024-2031
10.5.3. Middle East & Africa ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts Type of Molecules, 2024-2031
10.5.4. Middle East & Africa ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts End Users, 2024-2031
10.5.5. Middle East & Africa ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Therapeutic Areas, 2024-2031
10.5.6. Middle East & Africa ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
Chapter 11. Competitive Landscape
11.1. Major Mergers and Acquisitions/Strategic Alliances
11.2. Company Profiles
11.2.1. Thermo Fisher Scientific Inc.
11.2.2. Promega Corporation
11.2.3. Agilent Technologies, Inc.
11.2.4. Charles River Laboratories
11.2.5. RTI International
11.2.6. Eurofins Scientific
11.2.7. Evotec
11.2.8. Galapagos
11.2.9. Tecan Group
11.2.10. GVK Biosciences
11.2.11. Pharmaron
11.2.12. Pharmaceutical Product Development (PPD)
11.2.13. Sai Life Sciences
11.2.14. Shanghai Medicilon
11.2.15. Syngene International
11.2.16. WuXi AppTec
Global ADME Toxicology Testing Market -Type of Services
Global ADME Toxicology Testing Market – Type of Assays
Global ADME Toxicology Testing Market – Type of Molecules
Global ADME Toxicology Testing Market – End Users
Global ADME Toxicology Testing Market – Therapeutic Areas
Global ADME Toxicology Testing Market – By Region
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-